AGP Executive Report
Last update: 3 hours agoCBD Market Access: MediPharm Labs launched a full-spectrum CBD oral oil in Brazil through local partner Alko, following ANVISA authorization. The product is made at MediPharm’s GMP-certified Ontario facility, opening a route into one of the world’s tightly regulated cannabinoid markets. Hemp Rules: A federal overhaul set for Dec. 11 could remove many hemp-derived THC drinks, gummies and oils from U.S. convenience and grocery shelves. Some retailers say these products drive a substantial share of sales. Medicinal Cannabis: An ACT inquiry has advised against a proposed roadside-testing exemption for medicinal cannabis patients for now, citing unresolved questions about impairment and road safety; patients say the current rules can discourage them from using prescribed treatment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.